Cover Image
市場調查報告書

Aeolus Pharmaceuticals, Inc.:產品平台分析

Aeolus Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253762
出版日期 內容資訊 英文 36 Pages
訂單完成後即時交付
價格
Back to Top
Aeolus Pharmaceuticals, Inc.:產品平台分析 Aeolus Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年03月11日 內容資訊: 英文 36 Pages
簡介

Aeolus Pharmaceuticals, Inc.是從有害的放射線和活性氧的誘導因子到保持健康組織的催化劑抗氧化物質的新級平台的開發,投入力量的生物製藥公司。該公司開發對化學、放射性物質武器的醫學對策的AEOL 10150接受美國衛生及公共服務部的補助金。

本報告提供Aeolus Pharmaceuticals, Inc.的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、各分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Aeolus Pharmaceuticals, Inc.的基本資料

  • Aeolus Pharmaceuticals, Inc.概要
  • 主要資訊
  • 企業資料

Aeolus Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Aeolus Pharmaceuticals, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Aeolus Pharmaceuticals, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Aeolus Pharmaceuticals, Inc.:藥物簡介

  • AEOL-10150
  • AEOL-1114B
  • AEOL-11203
  • AEOL-11207
  • AEOL-10171

Aeolus Pharmaceuticals, Inc.:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Aeolus Pharmaceuticals, Inc.:最近的開發平台趨勢

Aeolus Pharmaceuticals, Inc.:暫停中的計劃

Aeolus Pharmaceuticals, Inc.:開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • deligoparin sodium
    • AEOL-10150
  • ■Aeolus Pharmaceuticals, Inc.:企業發表
  • ■Aeolus Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06841CDB

Summary

Global Markets Direct's, 'Aeolus Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Aeolus Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aeolus Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Aeolus Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Aeolus Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Aeolus Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Aeolus Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Aeolus Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Aeolus Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Aeolus Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aeolus Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Aeolus Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Aeolus Pharmaceuticals, Inc. Snapshot
    • Aeolus Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Aeolus Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Aeolus Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Aeolus Pharmaceuticals, Inc. - Pipeline Products Glance
    • Aeolus Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Aeolus Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Aeolus Pharmaceuticals, Inc. - Drug Profiles
    • AEOL-10150
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AEOL-1114B
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AEOL-11203
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AEOL-11207
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AEOL-10171
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Aeolus Pharmaceuticals, Inc. - Pipeline Analysis
    • Aeolus Pharmaceuticals, Inc. - Pipeline Products by Target
    • Aeolus Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Aeolus Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Aeolus Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Aeolus Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Aeolus Pharmaceuticals, Inc. - Dormant Projects
  • Aeolus Pharmaceuticals, Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • deligoparin sodium
      • AEOL-10150
  • Aeolus Pharmaceuticals, Inc. - Company Statement
  • Aeolus Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Aeolus Pharmaceuticals, Inc., Key Information
  • Aeolus Pharmaceuticals, Inc., Key Facts
  • Aeolus Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Aeolus Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Aeolus Pharmaceuticals, Inc. - Phase I, 2015
  • Aeolus Pharmaceuticals, Inc. - Preclinical, 2015
  • Aeolus Pharmaceuticals, Inc. - Discovery, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Aeolus Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Aeolus Pharmaceuticals, Inc. - Dormant Developmental Projects,2015
  • Aeolus Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2015
  • Aeolus Pharmaceuticals, Inc., Subsidiaries

List of Figures

  • Aeolus Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Aeolus Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Aeolus Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top